NASDAQ:TRAX | Free Cash Flow | First Tracks Biotherapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2025-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$32.56M$17,000.00-$32.58M
2025-03-31-$45.01M$35,000.00-$45.04M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.